In Brief: Comment period extensions
This article was originally published in The Tan Sheet
Executive Summary
Comment period extensions: FDA extends to Sept. 20 (from July 22) comment periods for two April 22 Federal Register notices: a final rule for OTC sodium labeling that sought comment on whether the reg should apply to OTC laxatives and oral care products, and a notice of proposed rulemaking that would require orally-ingested OTC drugs to be labeled for certain levels of calcium, magnesium and potassium ("The Tan Sheet" April 29, p. 8)...